Changes in Liver Function Tests, Congestion, and Prognosis After Acute Heart Failure
Lower ALT was associated with lower body mass index and more congestion in AHF, supporting previous studies suggesting ALT as a sarcopenia marker. The beneficial effect of HIC on health status was greater in low baseline ALT patients. (Safety, Tolerability and Efficacy of Rapid Optimization, Helped by NT-proBNP testinG, of Heart Failure Therapies [STRONG-HF]; NCT03412201).
Authors
- Kamilė Čerlinskaitė‐Bajorė (ORCID: https://orcid.org/0000-0002-6753-9356)
- Koji Takagi (ORCID: https://orcid.org/0000-0003-0213-1509)
- Marianela Barros
- Rafael Díaz (ORCID: https://orcid.org/0000-0003-2181-9579)
- Piotr Ponikowski (ORCID: https://orcid.org/0000-0002-3391-7064)
- Gerasimos S Filippatos (ORCID: https://orcid.org/0000-0002-5640-0332)
- Maria Novosadova
- Karen S Sliwa (ORCID: https://orcid.org/0000-0002-8272-0911)
- Chris Edwards (ORCID: https://orcid.org/0000-0002-0585-2697)
- Jelena Čelutkienė (ORCID: https://orcid.org/0000-0003-3562-9274)
- Antoine Kimmoun (ORCID: https://orcid.org/0000-0002-5443-2074)
- Ayelet Grupper (ORCID: https://orcid.org/0000-0002-5590-9428)
- Marco Metra (ORCID: https://orcid.org/0000-0001-6691-8568)
- Peter S. Pang (ORCID: https://orcid.org/0000-0003-3444-2811)
- Mattia Arrigo (ORCID: https://orcid.org/0000-0003-4028-2869)
- Daniela Tomasoni (ORCID: https://orcid.org/0000-0002-7584-2857)
- Ovidiu Chioncel (ORCID: https://orcid.org/0000-0002-3197-3628)
- Gad Cotter (ORCID: https://orcid.org/0000-0002-9613-3339)
- Étienne Gayat (ORCID: https://orcid.org/0000-0002-3334-3849)
- Peder Langeland Myhre (ORCID: https://orcid.org/0000-0002-5871-1804)
- Adriaan A. Voors (ORCID: https://orcid.org/0000-0002-5417-4415)
- Jan Biegus (ORCID: https://orcid.org/0000-0001-9977-7722)
- Alain Cohen‐Solal (ORCID: https://orcid.org/0000-0003-1055-2231)
- Benjamin Deniau
- Alexandre Mebazaa (ORCID: https://orcid.org/0000-0001-8715-7753)
- Matteo Pagnesi (ORCID: https://orcid.org/0000-0002-9298-7871)
- Jozine M. ter Maaten (ORCID: https://orcid.org/0000-0002-4910-9336)
- Albertino Antonio Moura Damasceno (ORCID: https://orcid.org/0000-0003-0925-494X)
- Beth Davison
- Hadiza Saidu
- Carolyn S.P. Lam
- Marianna Adamo
Institutions
- University Medical Center Groningen (NL)
- Inserm (FR)
- University of Cape Town (ZA)
- Carol Davila University of Medicine and Pharmacy (RO)
- Tel Aviv University (IL)
- Eduardo Mondlane University (MZ)
- University of Groningen (NL)
- Vilnius University (LT)
- University of Oslo (NO)
- National and Kapodistrian University of Athens (GR)
- Université Paris Cité (FR)
- Groote Schuur Hospital (ZA)
- Wroclaw Medical University (PL)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Régional et Universitaire de Nancy (FR)
- National University Heart Centre Singapore (SG)
- Hôpital Lariboisière (FR)
- Center for Pediatric Endocrinology Zurich (CH)
- Momentum Research (US)
- Estudios Clínicos Latinoamérica (AR)
- Instituto Cardiovascular de Rosario (AR)
- Indiana University School of Medicine
- Indiana University – Purdue University Indianapolis (US)
- University of Brescia (IT)
- Bayero University Kano (NG)
Publication Details
- Journal
- JACC Advances
- Published
- 2025-02-20
- DOI
- https://doi.org/10.1016/j.jacadv.2025.101607
- Citations
- 3
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 4.16
Funders
- American Heart Association
- Abbott Laboratories
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- Sanofi
- Alnylam Pharmaceuticals
- Edwards Lifesciences
- Boston Scientific Corporation
- LivaNova
- Strong
- Amarin Corporation
- Cytokinetics
- Moderna
- Novo Nordisk
- Vifor Pharma
- Servier
- Abbott Vascular
- Medical Research Council
- National Medical Research Council